Hielke Markerink

Mr. Hielke Markerink

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Medical Devices: Evidence and Research
Verified
Journal Article
Open access
PDF file
GGGeert-Jan van Geffen
Geert-Jan van Geffen
HMHielke Markerink
Hielke Markerink
MBMarc van Barneveld
Marc van Barneveld
FVFrank Verhoeven
Frank Verhoeven
GSGert Jan Scheffer
Gert Jan Scheffer
JBJörgen Bruhn
Jörgen Bruhn
Background: Obtaining complete topical anaesthesia of the airway remains a clinical challenge. Particle size is one of the most important variables for the dose deposited and the distribution of aerosols in the airways. The mass median aerodynamic diameter of the particles should be in the range of 5– 20 μm. We developed the “Trachospray” as a soft mist spray device for local anaesthetics. This in-vitro comparative test was designed to compare the performance of the new Trachospray device with two existing medical devices. The performance was determined by comparing the spray deposition patterns in the mouth, throat, trachea and lungs. Methods: The human airway was simulated with an artificial idealized mouth and throat model, connected to a Next Generation Impactor. Four measurements were taken for each device (Trachospray, jet nebulizer and a spray pump) with 5.85% NaCl. A fifth measurement was carried out with 0.5% fluorescein solution for a visual inspection of the deposition patterns. The mass median aerodynamic diameter and geometric standard deviation of the droplets were measured. Results: The Trachospray produced an even coverage in the mouth, hypopharynx and vocal cords, with only a small lung fraction. The jet nebulizer produced a much thinner layer coverage of the tongue and surface around the vocal chords with a high lung deposition. The spray pump produced big droplets which deposited mainly at the hypopharynx. Conclusion: The Trachospray device deposits local anaesthetics in the targeted areas for topical anaesthesia of the airway and has promising characteristics for providing effective airway anaesthesia.

5 January 2021 in Anaesthesia
Verified
Journal Article
Closed access
PDF file
GGG. J. van Geffen
G. J. van Geffen
HMHielke Markerink
Hielke Markerink
MBM. van Barneveld
M. van Barneveld
GSG. J. Scheffer
G. J. Scheffer
JBJ. Bruhn
J. Bruhn

19 January 2024 in Medicina
Verified
Journal Article
Open access
PDF file
HMHielke Markerink
Hielke Markerink
GGGeert-Jan van Geffen
Geert-Jan van Geffen
JBJörgen Bruhn
Jörgen Bruhn
Background: During endotracheal intubation, there is a 10% incidence of difficult laryngoscopy, which may result in serious complications. It is important to obtain as much information about the visibility of laryngeal structures before the patient is anaesthetised. Performing awake (video-) laryngoscopy on a patient is uncomfortable and can trigger gagging and coughing reflexes, making visualisation nearly impossible. The objective of this study is to evaluate the effectiveness of a soft mist spray device for airway anaesthesia during awake (video-) laryngoscopy. Methods: Twenty healthy volunteers inhaled through the Trachospray device, which was placed in their mouths. Two 2 mL syringes containing lidocaine at 4% were sprayed into the airway during inspiration. After several minutes, the subjects were asked to perform a videolaryngoscopy on themselves until the glottic structures and the vocal cords were visible. Upon completion of the procedure, all participants were asked to fill out a feedback form. Results: The duration of the videolaryngoscopy to visualisation of the vocal cords averaged 17 ± 13 s. After analysing the data, three distinct groups emerged as follows: Group 1 (70% of participants) showed no response, allowing for easy insertion of the videolaryngoscope. Group 2 (25% of participants) exhibited a light response but still permitted easy insertion and visualisation. One patient demonstrated a clear response with noticeable laryngeal contraction, requiring slightly more effort and discomfort for insertion. In 80% of the participants, the laryngeal structures were visualised according to Cormack–Lehane grade 1. All participants reported a high level of comfort, with an average rating of NRS 8. The anaesthesiologist assessed the level of anaesthesia as good to very good. No adverse events were observed. Conclusions: The Trachospray provided good, reliable, comfortable, and safe topical anaesthesia for awake videolaryngoscopy. This enables a direct visual assessment of the airway and may assist in making decisions regarding airway management for tracheal intubation.

27 January 2025 in Cureus
Verified
Journal Article
Open access
PDF file
RKRebecca M. Koch
Rebecca M. Koch
HMHielke Markerink
Hielke Markerink
RWRichard Witkam
Richard Witkam
JBJörgen Bruhn
Jörgen Bruhn
LELucas Van Eijk
Lucas Van Eijk
The emergence from general anesthesia is currently difficult to predict and may be accompanied by respiratory complications. Switching all hypnotic drugs to remimazolam at the end of the operation and antagonizing it with flumazenil might lead to a rapid, smooth, and safe patient awakening, potentially increasing operating theater efficiency and reducing costs. In this case series of five patients, anesthesia with a combination of remimazolam, propofol, and sevoflurane was transitioned to remimazolam at 0.9-1.0 mg/kg/h as the sole hypnotic agent near the end of the operation. Subsequently, remimazolam was antagonized with 0.5 mg flumazenil. This approach resulted in a rapid, predictable, and smooth emergence and recovery, free from excitation or hemodynamic and respiratory disturbances. Additionally, postoperative opioid requirements were minimal, and no anti-emetic medication was necessary. The authors conclude that the "switch and antagonize" concept is feasible and promising, warranting further evaluation and refinement in the near future.

10 September 2025 in Anesthesia Research
Verified
Journal Article
Open access
PDF file
HMHielke Markerink
Hielke Markerink
GGGeert-Jan van Geffen
Geert-Jan van Geffen
LELucas T van Eijk
Lucas T van Eijk
JBJörgen Bruhn
Jörgen Bruhn
Background: Topical anaesthesia of the nasal mucosa is essential for comfortable and effective nasal instrumentation. However, current methods often result in uneven anaesthesia, which can cause discomfort. This study evaluates the clinical performance of a newly developed soft mist nasal atomiser (NAA: Nasal Atomiser Adapter) for nasal topical anaesthesia. Methods: Twenty healthy adult volunteers received 1 mL of 4% lidocaine via the NAA in two doses of 0.5 mL each, administered into one nostril. Five minutes after administration, a size 7 nasopharyngeal airway was inserted into the anaesthetised nostril to assess tolerance. Comfort and anaesthetic effectiveness were rated by both participants and the attending anaesthesiologist using numeric rating scales (1–10). Results: The median total spraying time was 177.5 s (range, 152–192 s), which included the 120 s waiting period between the two 0.5 mL doses. Insertion of the nasopharyngeal airway took a median of 8.0 s (range 2–25 s). Participants rated the comfort of nasal lidocaine administration at a median of 9/10, and anaesthesia levels were rated as good to very good by both participants and clinicians. In 85% of cases, no reaction was observed during insertion of the nasopharyngeal airway; minimal reactions occurred in the remaining 15%. No adverse events were reported. Conclusions: The NAA provided effective, reliable, and safe anaesthesia of the nasal cavity, with a high level of comfort for the subject. It enabled fast and comfortable nasal instrumentation. These findings support the NAA as a promising alternative to conventional nasal anaesthetic techniques.